Genfit S.A. GNFTF
Set alert
9.43 USD 0.00 0.00%
At close · Oct 30
10.88 Day range 10.88
4.14 52-week range 16.50
- YTD
- +57.17%
- 1 year
- +153.49%
- Open
- 10.88
- Prev close
- 9.43
- Mkt cap
- 471.79M
- Vol
- 500
- Avg vol
- 85
- EPS
- -2.38
- P/E
- 0.00
More statistics
- Low
- 10.88
- High
- 10.88
2Y chart
Signals (29)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 21, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 10, 2026 | 3 months ago |
| SMA: Bullish | Jun 23, 2026 | 4 months ago |
| RSI: Overbought | Jun 23, 2026 | 4 months ago |
| SMA: Bearish | Jun 12, 2026 | 4 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| RSI: Overbought | Jun 11, 2026 | 4 months ago |
| MACD: Buy Signal | May 26, 2026 | 5 months ago |
| SMA: Bearish | May 1, 2026 | 6 months ago |
| RSI: Oversold | May 1, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 23, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 21, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 6, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 6, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 16, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 26, 2025 | 10 months ago |
| MACD: Sell Signal | Nov 19, 2025 | 11 months ago |
| MACD: Buy Signal | Oct 31, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 19, 2025 | 1 year ago |
| SMA: Bullish | Jul 25, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 25, 2025 | 1 year ago |
| RSI: Overbought | Jul 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 14, 2025 | 1 year ago |
| SMA: Bullish | Mar 5, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 10, 2025 | 1 year ago |
News
- Genfit S.A. (GNFTF) Discusses Developments and Guidance in MASH Diagnostics Transcript
- GENFIT: Positive Phase 1b Data with GNS561 in Combination Therapy in Heavily Pretreated Patients with Cholangiocarcinoma
- GENFIT: June 15, 2026 Combined Shareholders Meeting Results
- GENFIT: NASHnext®, Powered by GENFIT's Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp's OnDemand Offering for Identification of At-Risk MASH
- Stocks That Hit 52-Week Lows On Tuesday
Your note
Sign in to keep a note on GNFTF — it syncs with the Stock Master app.